WET AMD
Clinical trials for WET AMD explained in plain language.
Never miss a new study
Get alerted when new WET AMD trials appear
Sign up with your email to follow new studies for WET AMD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One-Time gene therapy could free wet AMD patients from lifelong eye injections
Disease control OngoingThis study tests a one-time gene therapy called RGX-314 for people with wet age-related macular degeneration (AMD), a leading cause of vision loss. The goal is to see if a single treatment can control the disease and reduce the need for repeated eye injections. About 671 adults a…
Matched conditions: WET AMD
Phase: PHASE2, PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
Eye drops could replace needles for wet AMD?
Disease control OngoingThis early-stage trial tests whether NT-101 eye drops can safely control wet age-related macular degeneration (AMD), a leading cause of vision loss. About 30 adults aged 50 and older with active wet AMD will use the drops for up to 8 weeks. The main goal is to check safety, but r…
Matched conditions: WET AMD
Phase: PHASE1, PHASE2 • Sponsor: NexThera Co., Ltd. • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC